Charles A. Dinarello
Department of Medicine
Division of Infectious Diseases
University of Colorado Denver
Aurora
USA
Name/email consistency: high
- Histone deacetylase inhibitors for treating a spectrum of diseases not related to cancer. Dinarello, C.A., Fossati, G., Mascagni, P. Mol. Med. (2011)
- Blocking interleukin-1β in acute and chronic autoinflammatory diseases. Dinarello, C.A. J. Intern. Med. (2011)
- Role of IL-1beta in type 2 diabetes. Dinarello, C.A., Donath, M.Y., Mandrup-Poulsen, T. Curr. Opin. Endocrinol. Diabetes. Obes (2010)
- Hyperosmolar sodium chloride, p38 mitogen activated protein and cytokine-mediated inflammation. Dinarello, C.A. Semin. Dial (2009)
- Historical insights into cytokines. Dinarello, C.A. Eur. J. Immunol. (2007)
- A signal for the caspase-1 inflammasome free of TLR. Dinarello, C.A. Immunity (2007)
- Inhibitors of histone deacetylases as anti-inflammatory drugs. Dinarello, C.A. Ernst Schering Res. Found. Workshop (2006)
- Interleukin 1 and interleukin 18 as mediators of inflammation and the aging process. Dinarello, C.A. Am. J. Clin. Nutr. (2006)
- The paradox of pro-inflammatory cytokines in cancer. Dinarello, C.A. Cancer Metastasis Rev. (2006)
- IL-32, a novel cytokine with a possible role in disease. Dinarello, C.A., Kim, S.H. Ann. Rheum. Dis. (2006)
- Blocking IL-1 in systemic inflammation. Dinarello, C.A. J. Exp. Med. (2005)
- Therapeutic strategies to reduce IL-1 activity in treating local and systemic inflammation. Dinarello, C.A. Curr. Opin. Pharmacol (2004)
- Infection, fever, and exogenous and endogenous pyrogens: some concepts have changed. Dinarello, C.A. J. Endotoxin Res. (2004)









